Article Versions Notes

Beloglazkina EK, Moiseeva AA, Tsymbal SA, Guk DA, Kuzmin MA, Krasnovskaya OO, Borisov RS, Barskaya ES, Tafeenko VA, Alpatova VM, et al. The Copper Reduction Potential Determines the Reductive Cytotoxicity: Relevance to the Design of Metal–Organic Antitumor Drugs. Molecules. 2024; 29(5):1032. https://doi.org/10.3390/molecules29051032

Beloglazkina, Elena K., Anna A. Moiseeva, Sergey A. Tsymbal, Dmitry A. Guk, Mikhail A. Kuzmin, Olga O. Krasnovskaya, Roman S. Borisov, Elena S. Barskaya, Victor A. Tafeenko, Victoria M. Alpatova, and et al. 2024. "The Copper Reduction Potential Determines the Reductive Cytotoxicity: Relevance to the Design of Metal–Organic Antitumor Drugs" Molecules 29, no. 5: 1032. https://doi.org/10.3390/molecules29051032

Beloglazkina, E. K., Moiseeva, A. A., Tsymbal, S. A., Guk, D. A., Kuzmin, M. A., Krasnovskaya, O. O., Borisov, R. S., Barskaya, E. S., Tafeenko, V. A., Alpatova, V. M., Zaitsev, A. V., Finko, A. V., Ol’shevskaya, V. A., & Shtil, A. A. (2024). The Copper Reduction Potential Determines the Reductive Cytotoxicity: Relevance to the Design of Metal–Organic Antitumor Drugs. Molecules, 29(5), 1032. https://doi.org/10.3390/molecules29051032